======= UGT8 =======
== Gene Information ==
* **Official Symbol**: UGT8
* **Official Name**: UDP glycosyltransferase 8
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7368|7368]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q16880|Q16880]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=UGT8&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UGT8|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601291|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Catalyzes the transfer of galactose to ceramide, a key enzymatic step in the biosynthesis of galactocerebrosides, which are abundant sphingolipids of the myelin membrane of the central nervous system and peripheral nervous system. {ECO:0000250|UniProtKB:Q09426}.
|Glyco tran 28 C|
|UDPGT|
|N-acylsphingosine galactosyltransferase activity|
|UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity|
|protein localization to paranode region of axon|
|galactosylceramide biosynthetic process|
|galactolipid biosynthetic process|
|glycosylceramide biosynthetic process|
|paranodal junction assembly|
|protein localization to axon|
|galactosylceramide metabolic process|
|galactolipid metabolic process|
|glycosylceramide metabolic process|
|myelin assembly|
|UDP-glycosyltransferase activity|
|glycosphingolipid biosynthetic process|
|ceramide biosynthetic process|
|glycosphingolipid metabolic process|
|glycolipid biosynthetic process|
|peripheral nervous system development|
|ceramide metabolic process|
|sphingolipid biosynthetic process|
|cellular component assembly involved in morphogenesis|
|cell-cell junction assembly|
|myelination|
|axon ensheathment|
|ensheathment of neurons|
|glycolipid metabolic process|
|liposaccharide metabolic process|
|membrane lipid biosynthetic process|
|cell-cell junction organization|
|sphingolipid metabolic process|
|cell junction assembly|
|membrane lipid metabolic process|
|cell junction organization|
|neuron projection morphogenesis|
|plasma membrane bounded cell projection morphogenesis|
|cell projection morphogenesis|
|cell part morphogenesis|
|amide biosynthetic process|
|lipid biosynthetic process|
|carbohydrate derivative biosynthetic process|
|neuron projection development|
|intracellular membrane-bounded organelle|
|cell morphogenesis|
|cellular amide metabolic process|
|neuron development|
|cellular component morphogenesis|
|anatomical structure formation involved in morphogenesis|
|cellular lipid metabolic process|
|central nervous system development|
|neuron differentiation|
|carbohydrate derivative metabolic process|
|cytoskeleton organization|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|lipid metabolic process|
|organonitrogen compound biosynthetic process|
|generation of neurons|
|cellular protein localization|
|cellular macromolecule localization|
|neurogenesis|
|cellular nitrogen compound biosynthetic process|
|cell development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.17|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18083
* **Expression level (log2 read counts)**: 2.47
{{:chemogenomics:nalm6 dist.png?nolink |}}